Join Dr. Richard Frye, MD, PhD, for an in-depth discussion of the metabolic challenges increasingly recognized in neurodevelopmental disorders. He will examine key pathways involved in clinical subgroups, including folate metabolism, mitochondrial dysfunction, oxidative stress, and immune-metabolic interactions, and discuss how these findings may help guide more individualized treatment strategies. Dr. Frye will also address therapeutic approaches such as folinic acid/leucovorin and the emerging role of photobiomodulation, highlighting why these interventions may be relevant for some patients and how they may fit into a broader biologically informed treatment framework.
